Article info

Download PDFPDF

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Authors

  1. Correspondence to Dr Jeremy Chataway; j.chataway{at}ucl.ac.uk
View Full Text

Citation

Connick P, De Angelis F, Parker RA on behalf of The UK Multiple Sclerosis Society Clinical Trials Network, et al
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Publication history

  • Received January 29, 2018
  • Revised June 18, 2018
  • Accepted June 20, 2018
  • First published August 30, 2018.
Online issue publication 
August 30, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.